Innate Pharma Overview
Innate Pharma Discounted Cash Flow
DCF Analysis for IPHA.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.13
Current Fair Value
$-0.13
↓ 107.5% Downside
Overvalued by 107.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison